Dr. Geleris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
622 W 168th St
New York, NY 10032Phone+1 212-305-2500Fax+1 212-305-3213- Is this information wrong?
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2014 - 2017
- Technion-Israel Inst of Technology Faculty of MedicineClass of 2014
Certifications & Licensure
- NY State Medical License 2017 - 2026
Publications & Presentations
PubMed
- 1 citationsUsing clinical decision support tools to increase defibrillator deactivations in dying patients.Ramsey Kalil, Daniel Y Choi, Joshua D Geleris, Jennifer I Lee, Michael P Wagner> ;BMJ Open Quality. 2022 Aug 1
- 17 citationsHospital Readmissions After Implementation of a Discharge Care Program for Patients with COVID-19 Illness.Siqin Ye, Grant Hiura, Elaine Fleck, Aury Garcia, Joshua Geleris, Paul S. Lee, Nadia Liyanage-Don, Nathalie Moise, Neil W. Schluger, Jessica R. Singer, Magdalena E. So...> ;Journal of General Internal Medicine. 2021 Jan 14
- 105 citationsBody Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection : A Retrospective Cohort Study.Michaela R. Anderson, Joshua Geleris, David Anderson, Jason Zucker, Yael R. Nobel, Daniel E. Freedberg, Jennifer L. Small-Saunders, Kartik N. Rajagopalan, Richard A. G...> ;Annals of Internal Medicine. 2020 Nov 17
- Join now to see all
Journal Articles
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19Joshua Geleris, Neil W Schluger, The New England Journal of Medicine
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19Joshua Geleris, Neil W Schluger, The New England Journal of Medicine
Authored Content
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19May 2020
Press Mentions
- The Efficacy and Safety of Hydroxychloroquine (HCQ) in Treatment of COVID19 –a Systematic Review and Meta-AnalysisMarch 26th, 2021
- All Hands on DeckDecember 23rd, 2020
- What Is Hydroxychloroquine? President Trump Calls It a COVID-19 Miracle Drug, but Many Scientists DisagreeMay 21st, 2020
- Join now to see all
Hospital Affiliations
- NewYork-Presbyterian/Columbia University Irving Medical CenterNew York, New York
- New York-Presbyterian HospitalNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: